HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Sys. Review
Review of metabolism-driven acylation modifications in COPD pulmonary cells
COPD May Be Driven by Hidden Cell Signals Doctors Can Now Target
This narrative review examines emerging acylation modifications like lactylation, succinylation, and crotonylation in pulmonary and immune c…
Hidden chemical tags in lung cells may drive COPD inflammation, opening paths for new targeted treatments and better biomarkers.
Frontiers
May 11, 2026
Drug Pipeline
Sys. Review
Narrative review discusses EV-associated non-coding RNAs in paediatric asthma
New Clues Found in How Child Asthma Changes Airways
This narrative review examines the role of extracellular vesicle-associated non-coding RNAs in paediatric asthma. The authors note that most…
Tiny cell messengers may reveal why some children develop severe asthma, opening paths to new tests and treatments.
Frontiers
May 7, 2026
Allergy & Immunology
Meta-analysis
Switching Biologics in Severe Asthma Patients Shows Improved Clinical Outcomes and Reduced Exacerbations Across Multiple Therapies
Switching Asthma Drugs Could Change Your Life
A systematic review and meta-analysis of 2,292 patients found that switching biologics significantly reduced exacerbations and improved asth…
If your severe asthma medication stops working, switching to a different biologic drug could cut your attacks in half and help you breathe e…
May 5, 2026
Palliative Care
Meta-analysis
Systematic review and meta-analysis on face-directed fan therapy for dyspnea in advanced disease
A simple fan eases severe breathlessness in palliative care
This meta-analysis of 463 subjects found that face-directed fan therapy significantly reduced immediate dyspnea in adults with advanced dise…
A simple bedside fan can quickly ease the distressing feeling of breathlessness for adults with advanced illness, offering a safe and afford…
May 5, 2026
Rheumatology
Guideline
Expert consensus guidelines for N-acetylcysteine use in various respiratory conditions
Experts share new guidance on using N-acetylcysteine for lung health
This expert consensus guideline reviews the clinical utility of N-acetylcysteine (NAC) across several respiratory diseases. The authors sugg…
Medical experts have reached a consensus on how a specific supplement might help people managing various chronic lung diseases.
Frontiers
May 4, 2026
Pulmonology & Critical Care
Meta-analysis
Meta-analysis shows biologic therapies reduce annual exacerbations in COPD patients with high eosinophils while maintaining safety profiles
New drugs cut COPD flare-ups for patients with high eosinophils
This living evidence synthesis evaluates dupilumab and mepolizumab in 7,359 COPD patients. Results indicate reduced annual exacerbation rate…
New biologic drugs lower the yearly number of COPD flare-ups for patients with high eosinophil counts while keeping side effects low
May 3, 2026
Pulmonology & Critical Care
Meta-analysis
Meta-analysis finds balance training improves balance in COPD patients receiving pulmonary rehabilitation
Adding Balance Training to COPD Rehab Changes Lives
This meta-analysis of seven randomized trials in COPD patients aged 50 years or older found that adding balance training to pulmonary rehabi…
A simple addition to standard lung rehab, balance training, helps COPD patients stand steadier, feel more confident, and live better, a new …
May 3, 2026
Pulmonology & Critical Care
FDA Approval
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance
FDA approves new triple-combination inhaler Breztri Aerosphere for COPD.
The FDA approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for maintenance treatment of COPD. It is a triple-combin…
The FDA approved Breztri Aerosphere, a triple-combination inhaler, for the long-term treatment of chronic obstructive pulmonary disease (COP…
FDA
May 2, 2026
Allergy & Immunology
RCT
New propellant HFA-152a in BDP/FF/G pMDI shows similar efficacy to HFA-134a in asthma
Trial shows HFA-152a and HFA-134a deliver equal lung function for asthma
This 12-week randomized controlled trial in 553 adults with moderate-to-severe controlled asthma found that BDP/FF/G delivered via HFA-152a …
A new trial found that two asthma inhaler propellants provided the same immediate lung function boost, with fewer side effects in one group.
May 1, 2026
Allergy & Immunology
Meta-analysis
Systematic review and meta-analysis links swimming pool attendance to increased asthma risk in children
Swimming Pool Time May Raise Asthma Risk For Kids
This systematic review and meta-analysis evaluated the association between swimming pool attendance and the risk of allergic diseases in 54,…
New research shows swimming pool attendance may increase asthma risk for children but does not appear to affect other common allergies.
May 1, 2026
Palliative Care
RCT
Nurse and social worker telecare team intervention improved quality of life in high-risk patients with COPD, heart failure, or interstitial lung disease
Telecare Team Helps Heart And Lung Patients Feel Better For Less Cost
This randomized clinical trial evaluated a nurse and social worker telecare team intervention (ADAPT) in high-risk patients with chronic obs…
A simple phone call from a care team can significantly improve how patients feel and function while keeping costs low.
May 1, 2026
Allergy & Immunology
RCT
Montelukast vs Tiotropium Added to ICS in Children With Asthma
Asthma Treatment Comparison Shows Mixed Results for Kids
This randomized controlled trial in 152 children aged 6 to 14 years with partly controlled or uncontrolled asthma found no significant diffe…
A small trial found no clear difference between two asthma medicines for children, though one caused rare side effects.
May 1, 2026